Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07111988
PHASE2
Valbenazine in Obsessive Compulsive Disorder
Sponsor: University of Chicago
View on ClinicalTrials.gov
Summary
The primary aim of the study is to examine the efficacy and safety of valbenazine in adults with moderate to severe obsessive-compulsive disorder (OCD).
Official title: Valbenazine in Obsessive-compulsive Disorder: A Randomized Double-blind Placebo-controlled Crossover Trial
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-02
Completion Date
2027-12
Last Updated
2026-02-05
Healthy Volunteers
No
Conditions
Interventions
DRUG
Valbenazine
Selective vesicular monoamine transporter 2 (VMAT2) inhibitor
DRUG
Placebo
Pill that contains no medicine